| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99199 |
Unlisted special service, procedure or report |
369,281 |
188,618 |
$2.38M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
28,993 |
26,048 |
$1.71M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,582 |
12,936 |
$1.26M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
7,853 |
7,202 |
$675K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
7,634 |
6,816 |
$649K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
6,591 |
5,979 |
$578K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
24,043 |
22,196 |
$462K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
12,646 |
11,679 |
$406K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,877 |
3,540 |
$367K |
| D0145 |
Oral evaluation for a patient under three years of age |
3,732 |
3,514 |
$129K |
| 96127 |
|
21,189 |
18,840 |
$123K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
11,972 |
11,016 |
$115K |
| 99215 |
Prolong outpt/office vis |
792 |
647 |
$93K |
| D1206 |
Topical application of fluoride varnish |
3,685 |
3,479 |
$55K |
| 87428 |
|
782 |
677 |
$46K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,574 |
1,254 |
$34K |
| 90474 |
|
1,596 |
1,496 |
$31K |
| 92583 |
|
1,156 |
1,010 |
$28K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
764 |
589 |
$26K |
| 96161 |
|
6,365 |
5,698 |
$23K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,616 |
1,504 |
$21K |
| 99417 |
Prolong home eval add 15m |
79 |
72 |
$13K |
| 83718 |
|
1,159 |
1,094 |
$11K |
| 90686 |
|
6,729 |
6,134 |
$8K |
| 0071A |
|
147 |
116 |
$8K |
| 0072A |
|
123 |
105 |
$7K |
| 90651 |
|
289 |
274 |
$7K |
| 82465 |
|
1,164 |
1,099 |
$6K |
| 83655 |
|
320 |
293 |
$4K |
| 99381 |
|
40 |
39 |
$3K |
| 96160 |
|
855 |
773 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
1,002 |
887 |
$3K |
| 80061 |
Lipid panel |
155 |
152 |
$2K |
| 69210 |
|
50 |
42 |
$2K |
| 90734 |
|
66 |
65 |
$2K |
| 99051 |
|
77 |
67 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
75 |
75 |
$811.36 |
| 90473 |
|
28 |
28 |
$584.84 |
| 87807 |
|
39 |
38 |
$494.55 |
| 90619 |
|
112 |
84 |
$457.47 |
| 94664 |
|
43 |
43 |
$451.33 |
| 90688 |
|
664 |
654 |
$441.45 |
| 90672 |
|
87 |
86 |
$291.94 |
| 90656 |
|
605 |
580 |
$281.10 |
| 92551 |
|
519 |
503 |
$244.00 |
| 90633 |
|
599 |
571 |
$129.52 |
| 81002 |
|
60 |
57 |
$126.33 |
| 81003 |
|
47 |
38 |
$101.64 |
| 90715 |
|
37 |
25 |
$99.36 |
| 99173 |
|
3,968 |
3,813 |
$68.89 |
| 94760 |
|
395 |
337 |
$51.02 |
| 90670 |
|
3,076 |
2,901 |
$48.01 |
| 90671 |
|
618 |
552 |
$4.08 |
| 90677 |
|
396 |
386 |
$0.74 |
| 90697 |
|
769 |
678 |
$0.21 |
| 1128F |
|
23,885 |
19,857 |
$0.01 |
| 90680 |
|
1,617 |
1,516 |
$0.00 |
| 1127F |
|
7,874 |
6,609 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,917 |
1,794 |
$0.00 |
| 90647 |
|
1,034 |
1,003 |
$0.00 |
| 91307 |
|
348 |
270 |
$0.00 |
| 90723 |
|
1,181 |
1,145 |
$0.00 |
| 90620 |
|
50 |
49 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
43 |
43 |
$0.00 |
| 99000 |
|
79 |
63 |
$0.00 |
| 90716 |
|
32 |
26 |
$0.00 |
| 90696 |
|
16 |
12 |
$0.00 |
| 90687 |
|
96 |
96 |
$0.00 |
| 90685 |
|
602 |
600 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
246 |
231 |
$0.00 |
| G9920 |
Screening performed and negative |
68 |
65 |
$0.00 |
| 91300 |
|
30 |
25 |
$0.00 |
| 90707 |
|
32 |
26 |
$0.00 |
| 90710 |
|
16 |
12 |
$0.00 |